Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients.

Authors:
Fang F; Lan XX; Hu RH; Hui WH; Zhao H and 5 more

Journal:
Ther Adv Neurol Disord

Publication Year: 2024

DOI:
10.1177/17562864231219151

PMCID:
PMC10823847

PMID:
38288324

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Neurol Disord

Abbreviation: Ther Adv Neurol Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to ide…
Fleischer M; Szepanowski F; Mausberg AK and 6 more (2024) - Transparency Score: 3/6
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis.
Faissner S; Bongert M; Trendelenburg P and 4 more (2024) - Transparency Score: 3/6
Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study.
Wang Y; Huan X; Zhu X and 9 more (2024) - Transparency Score: 3/6
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifyin…
Butzkueven H; Kalincik T; Patti F and 16 more (2024) - Transparency Score: 3/6
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decisio…
Hoffmann O; Gold R; Meuth SG and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support was provided by the Beijing Natural Science Foundation (Grant No. Z200022)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025